TechMates

TechMates

Welcome to TechMates, the podcast where we spotlight the trailblazing founders and game-changing startups transforming Australasia. Hosted by Mark Pavlyukovskyy, a Silicon Valley success story, and Hendrik Remigereau, a former leader in Europe’s largest AI ecosystem turned venture capitalist, TechMates dives deep into the counterintuitive mindsets and bold strategies that drive extraordinary achievements. Powered by NZVC, the venture firm backing the next generation of iconic companies from New Zealand and beyond, TechMates offers fresh perspectives on the people and ideas shaping the future

  1. From Edge to Epicenter: Building the NZ Innovation Ecosystem | NZVC Portfolio Day

    NOV 6

    From Edge to Epicenter: Building the NZ Innovation Ecosystem | NZVC Portfolio Day

    How founders, investors, and institutions are shaping the next decade of ANZ innovation. Live on stage with TechMates (hosts Mark Pavlyukovskyy & Hendrik Remigereau), three heavyweight voices dive into the state of the NZ startup ecosystem: Shaun Quincey (rowed the Tasman; now building Simfuni for insurers), Janine Grainger (co-founded Easy Crypto; exited earlier this year), and Jacques Richter (Investment Director at NZ Growth Capital Partners, managing the Aspire seed fund). They get specific on what’s great here—access, trust, regulators who take meetings—and what’s hard: under-capitalization, distance, and the cultural “tall poppy” tax on big ambition. This panel strips out the fluff: how to use New Zealand as a sandbox then go global, why “enterprise infiltration” is a real skill, what investors actually fund at seed, and why exits, mafias, and more diverse founders are the next unlock. You’ll also hear hard numbers on ecosystem growth (6× since 2019) and a challenge to scale from ~1,000 to 5,000 startups in the pipeline. 🌏 NZ as incubator → world as market: high-trust access, global translation is the test. 🏛️ Regulation: open-door chats vs “regulation by enforcement” overseas.🧭 Enterprise infiltration: find the real buyer, ask for money early. 💸 Capital & culture: the comfy $10M plateau, under-capitalization, and fund size reality. 🌿 Tall poppy & ambition: cheer louder, tell a bigger story, survive the pivots. 👩‍💻 Diversity matters: “stop funding the same founder mold”; women still under-funded.🧑‍🤝‍🧑 Talent & bravery: remote-first teams, culture as hiring edge, lower the barrier for movers. 📊 Ecosystem math: 6× EV since 2019; aim for ~5,000 startups, not ~1,000. Connect with the Guests Shaun Quincey — https://www.linkedin.com/in/shaun-quincey-53548132 Janine Grainger — https://www.linkedin.com/in/janine-grainger Jacques Richter — https://www.linkedin.com/in/jacques-richter-a216b324 Learn more about NZVC & Hosts NZVC: https://www.nzvc.co.nz Mark Pavlyukovskyy: https://www.linkedin.com/in/pavlyukovskyy/ Hendrik Remigereau: https://www.linkedin.com/in/hendrik-remigereau-09a03067/ If this sharpened your startup/business brain, hit 👍 and subscribe for more New Zealand founder deep-dives. 00:00 – Intro 02:59 – Would you build again in New Zealand? 04:21 – Working with regulators in New Zealand vs. abroad 05:18 – Investor perspective on scaling beyond NZ 06:28 – Comparison with building companies in Germany 06:50 – Pros and cons of building from NZ (Sean on access and ambition) 08:17 – The $10M lifestyle business trap in NZ 08:40 – Under-capitalization and growth of local VC ecosystem 10:12 – The importance of startup “mafias” in NZ 11:01 – Janine on exiting and mentoring new founders 12:28 – Investor view: learning from exits and spinouts 12:52 – Mark and Janine on founder culture in Silicon Valley 14:25 – Developing startup culture and access for new founders 15:29 – Underselling ambition: the Kiwi mindset 16:41 – Sean on Tall Poppy syndrome 17:57 – Janine on selling to an Australian company and founder ambitions 19:53 – Jacques on VC fund maturity and exit sizes 20:46 – How investors decide which founders to back 22:19 – What investors look for: meaningful problems and narratives 23:18 – What needs to change in the NZ startup ecosystem? 23:47 – Sean’s vision: capital, education, and share options reform 26:00 – Janine: Stop investing only in “Mark Zuckerberg types” 26:53 – Jacques: NZ’s VC growth and what’s next 28:22 – Audience question: Where do the best startup ideas come from? 30:15 – The role of passion in solving problems 31:03 – Human capital and building great workplaces 32:00 – Sean on attracting global talent to NZ 33:10 – Discussion: Is NZ talent density enough? #startups, #NewZealand, #business, #venturecapital, #founders, #regulation, #talent, #ESOP, #globalexpansion, #womenintech, #innovation, #fintech, #crypto, #AI, #robotics, #ecosystem, #SaaS, #NZTech, #TechMates, #podcast

    35 min
  2. Beyond Startup Hype: 5 Founders on Real Difficulties

    OCT 30

    Beyond Startup Hype: 5 Founders on Real Difficulties

    Five New Zealand–linked founders drop hard-won truths! This highlight episode brings together five New Zealand tech entrepreneurs at very different stages—Shaun Quincey, Liam Kampshof, Nick Damiano, Steven Zinsli, and Anna Henwood. It’s a punchy reel of what actually moves the needle in startups: selling into enterprise, building brutally simple products, and staying alive long enough for the compounding to kick in. You’ll hear why enterprise sales is a “dark art” that starts by finding the real buyer, the founder mindset of “stop what’s not working and don’t die,” the moment a recap turns an engineer into a founder, and why loving uncertainty can keep you in the game for 15 years. 🕸️ Enterprise infiltration: map budget cycles, find the true decision-maker, ask for money early. 🧰 Prototype grit: shower tests, mastitis milk samples, and a raincoat-and-laptop cowshed setup. 🔁 Pivot discipline: “stop doing the wrong thing,” survive, and let time create trust. 🧠 Founder trigger: when a recap pushes a product-first engineer to build their own company. 🎢 Roller-coaster reality: loving uncertainty, community, and autonomy in startups. 🤖 AI & robotics: software-first medtech, simple sensors over dashboards, and pragmatic adoption. 💼 Go-to-market: from field demos to enterprise programs that actually close. Connect with the Guests: Shaun Quincey — https://www.linkedin.com/in/shaun-quincey-53548132 Nick Damiano — https://www.linkedin.com/in/nickdamiano Liam Kampshof — https://www.linkedin.com/in/liam-kampshof Steven Zinsli — https://www.linkedin.com/in/steven-zinsli-💳-aa813184 Anna Henwood — https://www.linkedin.com/in/anna-henwoodLearn more about NZVC & HostsNZVC: https://www.nzvc.co.nz Mark Pavlyukovskyy: https://www.linkedin.com/in/pavlyukovskyy/ Hendrik Remigereau: https://www.linkedin.com/in/hendrik-remigereau-09a03067/ Timestamps: 00:00 — Intro00:30 — Shaun on “enterprise infiltration” and finding the buyer 03:31 — Liam’s prototypes and cowshed data 04:32 — Steven: stop what’s wrong, don’t die, play the long game 06:26 — Nick: a recap, a product plan, and the founder decision 08:00 — Anna: the roller coaster, autonomy, and loving uncertaintyIf this sharpened your startup/business brain, hit 👍, drop your questions for the founders below, and subscribe for more New Zealand founder deep-dives. #startups, #business, #NewZealand, #AI, #robotics, #agtech, #fintech, #insurtech, #SaaS, #venturecapital, #productmarketfit, #founderstory, #enterprise, #B2B, #medtech, #marketresearch, #dairy, #compliance, #innovation, #podcast

    13 min
  3. Why Big Tech Failed at This Simple Farming Task

    OCT 9

    Why Big Tech Failed at This Simple Farming Task

    🐄 Engineer Liam Kampshof turned an early milking-shed prototype into a simple, low-cost sensor now used on 145+ New Zealand farms, catching mastitis early to protect milk quality and payouts! Liam is a New Zealand tech entrepreneur and founder of Bovonic, makers of QuadSense—a snap-in, battery-powered sensor that measures each teat’s conductivity in real time, compares quarters, and throws a red light in ~30 seconds if mastitis is likely. It retrofits into the short milk tube, has no moving parts, a ~3-year battery life, and costs ~5× less than legacy lab systems—so farmers actually install it. 🐄 Mastitis 101: why manual “stripping” fails at scale and how quarter-level conductivity catches it earlier. 📈 Adoption: ~145 farms (≈2% NZ) in year one; near 5% in early regions; hardware + profitability. 🧭 NZ edge: no subsidies → ruthless ROI; “number-8 wire” practicality meets biomedical chops. 🥛 Macro: NZ = #1 dairy exporter (not producer); EU cell-count standards and antibiotic rules shaping demand. Connect with the Guest: Liam Kampshof — LinkedIn: https://www.linkedin.com/in/liam-kampshof Company (Bovonic / QuadSense): https://bovonic.com Learn more about NZVC & Hosts NZVC: https://www.nzvc.co.nz Mark Pavlyukovskyy: https://www.linkedin.com/in/pavlyukovskyy/ Hendrik Remigereau: https://www.linkedin.com/in/hendrik-remigereau-09a03067/ 00:00 — Intro & NZ dairy roots 01:11 — Farm childhood in Waikato & Bay of Plenty 07:16 — Choosing Biomedical Engineering at Auckland 10:16 — London deep-tech: DNA Electronics sepsis project 21:10 — Back to NZ during COVID; MIQ and reset 23:41 — The mastitis problem & why manual checks fail 31:17 — Why quarter-level conductivity is the unlock 37:47 — First prototypes; cowshed raincoat + laptop tests 41:07 — Fieldays validation: 110–120 signups; pre-orders 45:56 — QuadSense demo: sensor in the short milk tube 48:38 — Red-light alerts in ~30s; 3-year batteries; self-install 54:22 — 145 farms live; ~2% market; ~5% in early regions 01:01:27 — NZ collar adoption shows ROI-driven uptake 01:03:41 — Global fit: UK/Ireland → EU → US plan 01:10:52 — Founder moving to UK to open markets 01:19:02 — NZ: top dairy exporter; 95–96% exported If this sharpened your startup/business brain, hit 👍, drop your questions for Liam below, and subscribe for more New Zealand founder deep-dives. #startups, #NewZealand, #business, #AgTech, #dairy, #dairyfarming, #animalhealth, #mastitis, #sensors, #hardware, #biomedicalengineering, #precisionagriculture, #farmtech, #veterinary, #robotics, #AI, #Fieldays, #NZTech, #founderstory, #TechMates

    1h 10m
  4. He Rowed the Tasman—Then Built and Sold a Fintech

    SEP 29

    He Rowed the Tasman—Then Built and Sold a Fintech

    He rowed solo across the Tasman, later sold his BNPL startup—now he’s rebuilding life insurance with AI from New Zealand. Our guest, Shaun Quincey, is a New Zealand tech entrepreneur who went from a 54-day solo ocean row to exiting a services-focused BNPL company—and now leads Simfuni, an AI-first operating platform for life insurers. He breaks down how a payments “wedge” became a full policy-admin + automation stack, and why eight insurers are already on the platform. We go deep on enterprise sales inside legacy insurers, using AI agents for real self-service (move payment dates, policy changes, docs), and the ethics of data, wearables, and genetics in underwriting. Plus: the early NZ accelerator days, a 7-figure exit with an earn-out, and what it really takes to survive 300 metaphorical “uppercuts” in startups. 🧭 From Singapore birth & military family → New Zealand childhood → resilience through constant change. 🚣 Rowing Australia→NZ solo at 23; 54 days, capsizes, a bestselling book—and startup lessons. 💳 BNPL in services (5k merchants) → strategic sale to Latitude; why timing beat ego. 🧠 Simfuni: payments wedge → policy admin OS → AI agents for customer ops. 🏢 “Enterprise infiltration”: who decides, budget cycles, and asking for money early. 🤖 What AI does today: automate common requests, cut FTEs, boost compliance. 📈 Eight life insurers live; AU/NZ focus with South Africa interest next. 🧬 Wearables & genetics: pricing fairness vs. privacy—where regulation lands. 🧱 Founder mindset: pivots, patience, and building for 5–10 years. Connect with the Guest Shaun Quincey — LinkedIn: https://www.linkedin.com/in/shaun-quincey-53548132 Company (Simfuni): simfuni.com Learn more about NZVC & Hosts NZVC: https://www.nzvc.co.nz Mark Pavlyukovskyy: https://www.linkedin.com/in/pavlyukovskyy/ Hendrik Remigereau: https://www.linkedin.com/in/hendrik-remigereau-09a03067/ Timestamps 00:00 – Introduction & welcome 01:20 – Shaun’s childhood in Singapore and New Zealand 03:30 – Growing up with constant change and resilience 06:00 – Family background and his father’s solo Tasman row 08:40 – Shaun’s own Tasman Sea adventure (rowing from Australia to NZ) 12:00 – Storms, setbacks, and pushing through challenges 15:00 – Writing a book and lessons learned from the row 19:00 – Transition into career and first job at Debit Success 28:30 – Exposure to startups and move to San Francisco 31:30 – Founding his first fintech startup (buy now, pay later) 35:30 – Growth, competition, and acquisition 41:00 – Reflections on exiting and lessons from competition 43:20 – Coming up with new startup ideas during earn-out 46:00 – Entering the insurance industry 50:30 – Cracking enterprise sales with insurers 53:00 – Building Simfuni: modernizing life insurance systems56:00 – How AI transforms insurance operations 59:00 – Understanding life insurance and underwriting 1:03:00 – Risk, reinsurance, and margins 1:05:30 – The future of AI in insurance 1:08:00 – Vision for Simfuni and closing thoughts If this sharpened your startup/business brain, hit 👍, drop your questions for Shaun below, and subscribe for more New Zealand founder deep-dives. #startups, #NewZealand, #business, #AI, #insurtech, #lifeinsurance, #enterprise, #SaaS, #automation, #fintech, #BNPL, #payments, #dataprivacy, #actuarial, #regtech, #customerexperience, #founderstory, #productmarketfit, #NZTech, #TechMates

    1h 25m
  5. Building the Tesla of Surgical Robots 🏥 #healthtech

    SEP 22

    Building the Tesla of Surgical Robots 🏥 #healthtech

    He’s turning an iPad into a surgical cockpit—and launching semi-autonomous surgery from New Zealand to the world. Nick Damiano is a Bay Area deep-tech founder with strong New Zealand ties: after building medtech across pacemakers, tele-presence OR support, and implantables (YC alum twice), he co-founded Andromeda to bring autonomous surgical robotics to market—faster and cheaper than the traditional medtech playbook. The bet: software-first robots that learn like self-driving cars, starting with urology and HOLEP (pioneered in Tauranga), guided on an iPad with “Google Maps for the prostate.” This episode gets real about why most medtech financing is broken, how to avoid co-founder minefields, what the FDA actually cares about, and why New Zealand is a killer launchpad for clinical studies and first-in-market deployments. It’s a masterclass in building deep tech with startup speed—plus bold takes on Intuitive (Da Vinci), disposables-free business models, and taking world-class surgery global. 🧠 From surgeon family → Stanford → engineering → startups. 🫀 Leadless pacing & ultrasound targeting algorithms at EBR. 🛰️ Avail/NewRep: remote OR support and the COVID tailwind. 🧩 Co-founder fit, intensity alignment, and conflict habits. 🧪 Zenflow (BPH): YC medtech, trials, and NZ clinical beachhead. 🤖 Andromeda: software-first surgical robots with iPad control. 🗺️ HOLEP + “Google Maps for the prostate” to de-risk learning. 🏥 FDA pragmatism, NZ fast-track launches, and global access. 💼 Business model: no disposables, subscription + partnerships. 🥊 Startups vs incumbents: where Da Vinci stops and autonomy starts. Connect with the Guest LinkedIn (Nick): www.linkedin.com/in/nickdamiano Company (Andromeda): https://www.andromedasurgical.com Learn more about NZVC & Hosts NZVC: https://www.nzvc.co.nz Mark Pavlyukovskyy: https://www.linkedin.com/in/pavlyukovskyy/ Hendrik Remigereau: https://www.linkedin.com/in/hendrik-remigereau-09a03067/ Timestamps 00:00 – Intro 01:07 – Nick’s medical family roots 02:53 – Stanford & switch from medicine to startups 07:38 – Early jobs & pacemaker innovation 11:47 – Founding Avail (NewRep) 17:39 – Medical device reps explained 20:33 – Lessons on co-founders & teams 27:29 – Company #2: ZenFlow29:19 – Getting into Y Combinator 34:34 – Why MedTech is so hard 40:25 – ZenFlow outcome & NZ connection 45:15 – Founding Andromeda: autonomous surgery 48:19 – What the Da Vinci robot does 52:34 – Andromeda’s unique approach 57:32 – Starting with prostate surgery (HoLEP) 1:00:26 – Navigating FDA approval 1:05:45 – Future of autonomous surgery If this sharpened your startup/business brain, hit 👍, drop your questions for Nick below, and subscribe for more New Zealand-powered deep-tech stories. #startups, #NewZealand, #business, #robotics, #AI, #medtech, #surgery, #urology, #HOLEP, #FDA, #YC, #YCombinator, #DaVinci, #autonomoussystems, #healthtech, #deeptech, #venturecapital, #founderstory, #Andromeda, #TechMates #healthtech

    1h 13m
  6. Exit at 27: Chasing Bigger Horizons 💳 #fintech

    SEP 7

    Exit at 27: Chasing Bigger Horizons 💳 #fintech

    From 15 clinics and 105,000 patients to a fintech rebrand and a tax ruling with IRD—this New Zealand founder turned “HealthNow” into Extraordinary, a benefits-payments platform winning banks, telcos, and airlines. Steve is a New Zealand tech entrepreneur who scaled an allied-health group to ~$12M revenue at 17–24% EBITDA before exiting at 27, then founded HealthNow—a healthcare BNPL/savings/employer-aid play that evolved into Extraordinary, a modular platform that lets companies control where benefits dollars get spent (travel, meals, gifting, health, more). This episode is a masterclass in ruthless iteration: kill the feature that doesn’t work, follow customer pull, then reprice and reframe until it clicks. What’s wild (and useful): how investor pushback killed the double-sided marketplace, why “breakage” beats “load fees,” and how a binding IRD ruling unlocked pre-tax public transport benefits—turning a compliance headache (FBT/PAYE) into a business moat. We also get candid about the emotional cost of a pivot, Darwinism for founders (“adapt or die”), and going enterprise (yes, sometimes… wear the suit). Key Topics 🩺 From clinics to fintech: scaling 15 sites, 120 staff, 105k patients—then exiting to build software. 💳 Why BNPL for healthcare didn’t pencil out—and the pivot to employer-funded benefits. 🧩 Modular platform & pricing psychology: per-employee + fixed “breakage,” not “card fees.” 🧾 Compliance moat: controlling spend categories, FBT vs PAYE, and audit-friendly rails. 🚌 IRD binding ruling: pre-tax public transport for employees (and why that matters). 🏢 Enterprise sales: telcos, banks, an airline—why credibility (and suits) count. 🔁 Founder mindset: grief of a pivot, “persist more than resist,” and 10-15 year time horizons. Connect with the Guest Steve — LinkedIn: https://www.linkedin.com/in/steven-zinsli-💳-aa813184 Company (Extraordinary): https://www.extraordinarypay.com Learn more about NZVC & Hosts NZVC: https://www.nzvc.co.nz Mark Pavlyukovskyy: https://www.linkedin.com/in/pavlyukovskyy/ Hendrik Remigereau: https://www.linkedin.com/in/hendrik-remigereau-09a03067/ Timestamps:00:00 – Intro 01:14 – Steve’s upbringing in Auckland 04:13 – Childhood experiences shaping healthcare passion 06:19 – Early lessons about healthcare costs 07:17 – School years and university path 10:26 – First steps in healthcare and scaling clinics 13:28 – Building a multi-clinic business 15:14 – Growing revenue and why Steve exited 17:14 – Shift from clinics to fintech in healthcare 26:45 – First concept of HealthNow 28:23 – Buy Now, Pay Later for healthcare 30:28 – Health savings accounts & employer aid 34:56 – Core problem: healthcare affordability 37:31 – Pivoting from healthcare to broader benefits 42:00 – Advice for founders facing pivots 45:39 – Startup persistence and survival 48:29 – Birth of Extraordinary from customer demand 50:01 – Modularizing the platform & pricing learnings 53:03 – Breakage and gift card economics 55:23 – Public transport benefit opportunity 58:41 – Outlook: next 1–5 years for Extraordinary 1:02:03 – Market size, competition, and growth potential 1:04:34 – Role models and inspiration 1:05:31 – Advice for founders in New Zealand 1:06:59 – Closing remarks If this sharpened your startup/business brain, hit 👍, drop your questions for Steve below, and subscribe for more New Zealand founder deep-dives. #startups, #business, #NewZealand, #fintech, #payments, #employeebenefits, #HRtech, #compliance, #FBT, #publictransport, #BNPL, #founderstory, #productmarketfit, #SaaS, #pricing, #B2B, #enterprise, #NZTech, #TechMates, #podcast

    1h 7m
  7. Healthcare is a $4.5 Trillion Broken System 💊

    AUG 31

    Healthcare is a $4.5 Trillion Broken System 💊

    Ari Tulla built, pivoted, exited, and is now using AI to rewire preventative health. Ari Tulla is a Finnish-born, SF-based tech entrepreneur who started in gaming and Nokia’s early app ecosystem, founded doctor-finder startup BetterDoctor (later rolled into a 500-person PE platform), and now leads Elo Health, a nutrition company turning biometrics + AI into real-world outcomes. He shares the gritty founder path: consumer → API pivot, exit, then the hard jump from software to atoms (supply chains, tariffs, fulfillment). This conversation gets unusually candid about what actually scales in healthtech: why “prevention” needs business-model innovation, where AI beats human pattern-recognition, and why even die-hard remote founders end up craving one room for speed and trust. We also roam from wearables and privacy to CRISPR, cloning ethics, and what he teaches his kids about building in an AI world.🧊 Finland roots ➜ Nokia’s app era ➜ Silicon Valley leap.🎮 From MUDs to mobile: early internet, world-building, and dev culture.🏢 Nokia lessons: platform bets, Symbian/MeeGo, and timing risk.🔁 Startup pivots: BetterDoctor—consumer → API/SaaS → PE roll-up.🧪 Elo’s thesis: AI + biomarkers + nutrition as preventative medicine.🤖 AI vs. doctors: pattern recognition, triage, and the “QB” model.💤 Sleep, stress, movement: building real-time feedback loops with wearables.🧬 Bio/ethics: cloning, CRISPR, and data rights in health.🏗️ Why you shouldn’t “recreate Silicon Valley.”🧑‍🍳 Team dynamics: remote reality vs. “one room” excellence. Connect with the Guest Ari Tulla — LinkedIn: Company (Elo): Learn more about NZVC & Hosts NZVC: https://www.nzvc.co.nz Mark Pavlyukovskyy: https://www.linkedin.com/in/pavlyukovskyy/ Hendrik Remigereau: https://www.linkedin.com/in/hendrik-remigereau-09a03067/ 00:00 Intro 01:50 Ari — Finland & early internet 07:00 Gaming (MUDs) & early dev connections 12:20 Nokia / Ovi Store & mobile apps 36:40 Entrepreneurship → BetterDoctor (growth & pivot) 44:10 Sale to PE & running bigger company 48:40 Elo.Health origin — nutrition & prevention52:00 Product experiments: blood tests, wearables, supplements 57:00 Sleep, stress & health-span discussion 01:17:00 Future plans & wrap-up. If this sharpened your startup/business brain, hit 👍, drop your questions for Ari below, and subscribe for more founder deep-dives. #startups, #business, #AI, #healthtech, #preventivemedicine, #nutrition, #wearables, #dataprivacy, #biotech, #NewZealand, #SiliconValley, #founderstory, #productmarketfit, #APIs, #PE, #longevity, #sleep, #stress, #wellness, #TechMates

    1h 25m
  8. Startups vs Hype: VeVe’s Real Web3 Business 👾🎮

    AUG 24

    Startups vs Hype: VeVe’s Real Web3 Business 👾🎮

    From $5 stamp packs on Queen Street to ~$1.5B in VeVe marketplace GMV—New Zealand entrepreneur David Yu built one of the world’s biggest digital collectibles businesses! David Yu—founder/CEO of VeVe—grew up in Taipei, moved to Auckland, and turned a teenage collecting habit into a retail chain, a global licensing career, and ultimately VeVe, the NFT platform behind 3D, AR-ready drops from top studios and car brands. He explains how years of community-building in hobby stores and a nose for IP deals translated to landing Marvel/DC/Disney, while making onboarding “frictionless” for mainstream collectors. We dig into real numbers and roadmap: ~600k funded/holding accounts, ~250k MAU, ~$1.45–1.5B+ secondary GMV, $300–400M primary sales, 4.5M+ digital comics, the launch of VVverse, and why the next wave is a creator economy built on fandom + AI. Plus: the first 3D Steamboat Willie, how to pitch licensors when the category “doesn’t exist,” and why Gen Z will value digital scarcity like previous generations prized paper comics. 🌏 From Taipei to New Zealand: retail → licensing → VV founder journey. 🧪 “Frictionless” onboarding and why Web3 UX has to feel Web2. 🤝 Pitching Disney/Marvel/DC when NFTs “sounded like a scam.” 📊 VV by the numbers: users, GMV, comics, brands, and AR features. 🏗️ VVverse and the rise of creator-built shops, galleries, and car dealers. 🚗 Licensing playbook: from Pokémon cards to Maserati/Lamborghini in AR. 🧠 AI’s role in content generation, NPCs, and smarter collecting. Connect with the Guest David Yu – LinkedIn: www.linkedin.com/in/davidyunzCompany (VeVe): https://www.veve.me Learn more about NZVC & Hosts NZVC: https://www.nzvc.co.nz Mark Pavlyukovskyy: https://www.linkedin.com/in/pavlyukovskyy/ Hendrik Remigereau: https://www.linkedin.com/in/hendrik-remigereau-09a03067/00:00:00 — Intro 00:02:26 — Origin: Taipei → Auckland; collecting → first businesses 00:09:39 — Pokémon boom & the power of community 00:19:04 — Expanding to Asia: China exports (WFOE) & licensing lessons 00:22:01 — Bentley stroller case — fighting grey-market/daigou 00:36:55 — From blockchain to CryptoKitties: the spark for VeVe 00:41:40 — Why digital collectibles win (space, logistics, Gen Z) 00:47:34 — App Store onboarding: no crypto hurdles 00:54:11 — Pitching Disney/Marvel with mockups & AR demos 00:58:24 — VeVe today: product verticals, key metrics, VV-Verse vision 01:12:43 — Beyond the 2021 hype: NFT recovery & outlook 01:18:55 — 5–15 years ahead: skills & asking AI better questions 01:21:31 — Favorite digital collectible (Steamboat Willie) & wrap-up If this sharpened your startup/business brain, smash 👍, drop your questions for David below, and subscribe for more New Zealand founder stories. #startups, #NewZealand, #business, #NFTs, #digitalcollectibles, #VeVe, #VVverse, #blockchain, #web3, #AI, #augmentedreality, #comics, #Marvel, #Disney, #licensing, #creatorEconomy, #gaming, #venturecapital, #TechMates, #podcast

    1h 25m

About

Welcome to TechMates, the podcast where we spotlight the trailblazing founders and game-changing startups transforming Australasia. Hosted by Mark Pavlyukovskyy, a Silicon Valley success story, and Hendrik Remigereau, a former leader in Europe’s largest AI ecosystem turned venture capitalist, TechMates dives deep into the counterintuitive mindsets and bold strategies that drive extraordinary achievements. Powered by NZVC, the venture firm backing the next generation of iconic companies from New Zealand and beyond, TechMates offers fresh perspectives on the people and ideas shaping the future